LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
Net selling: insiders sold $3.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $3.9M and bought $0 of CDNA stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. $875K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Goldberg, Michael (Director), who sold $2.1M. The latest filing was on Aug 6, 2026.
None. No member of Congress disclosed a CDNA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
No tracked top-trader positions in CDNA right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Adjusted EPS
$0.23 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $0.37 / $0.23Yahoo Finance | +59.48% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | $0.34 / $0.13Yahoo Finance | +$0.21 beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | $0.12 / $0.23Yahoo Finance | -47.06% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | $0.28 / $0.14Yahoo Finance | +97.64% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $0.10 / $0.12Alpha Vantage | -16.67% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | $0.10 / $0.07Alpha Vantage | +$0.03 beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 26, 2025 | $0.18 / $0.15Alpha Vantage | +22.03% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 4, 2024 | $0.14 / $0.01Alpha Vantage | +$0.13 beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $100.1M | $108.4M | $117.7M | $131.9M |
| Cost of what it sold | $30.7M | $35.5M | $33.6M | $35.0M |
| Gross profit | $69.4M | $72.9M | $84.1M | $97.0M |
| What it spent | ||||
| Research and development | $16.8M | $19.3M | $21.4M | $22.4M |
| Sales and admin | $28.4M | $28.7M | $30.5M | $40.9M |
| Other operating costs | $24.4M | $30.9M | $30.4M | $33.4M |
| Total operating expenses | $69.6M | $78.9M | $82.3M | $96.7M |
| What was left | ||||
| Operating profit | -$246.0K | -$6.0M | $1.8M | $257.0K |
| Profit before tax | $1.7M | -$3.8M | $2.8M | $114.5M |
| Tax | -$15.0K | $345.0K | -$32.0K | $3.9M |
| Net profit | $1.7M | -$4.1M | $2.8M | $110.6M |
| EBITDA | $4.9M | -$780.0K | $7.1M | $4.3M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
